Business Paid
Molecure approved for phase 2 trials of OATD-01 in UK
18:25
Molecure has received positive feedback from the ethical committee and the UK Medicines and Healthcare products Regulatory Agency for its Phase II study application of OATD-01 molecule in patients with active pulmonary sarcoidosis.
This article is for subscribers
Warsaw Business Journal subscribers get the full archive (12,248 articles going back to 1995) and the print edition.
SubscribeOr try Poland A.M. free for 7 days, the daily briefing, or see all plans and prices.
